Customer Service 1 (888) 261-2693
Please enter Search keyword. Advanced Search

The Cheapest Beachfront Around

By Tom Dyson, publisher, The Palm Beach Letter
Wednesday, August 6, 2008

I met Jack in the back of a taxi here in Malaysia. Jack is American. We shared a ride from the airport yesterday...

Jack asked me where I lived. When I told him I lived in Florida, he quickly turned the subject to real estate. It turns out, Jack got involved in the Miami condo bubble.

Jack knows nothing about real estate or investing. But in 2004, he and his wife bought two condos on Collins Avenue. Miami had two major construction booms: One boom ran along the beach on Collins Avenue. The other was downtown... in the financial district... around Biscayne Boulevard.

Jack's condos rose 15% through 2005. Let's say Jack put 10% money down. He had a 150% profit. Jack had intended to flip his condos, but when he saw how easy it was to make money in Miami's construction boom, he decided to let his profits run. Then the market collapsed...

Collins Avenue condos are now down around 15% from their peak, and the condos around Biscayne Boulevard have lost around 35%.

Jack's investment is back where it started. Except now Jack owns two condos no one wants to buy and he has to rent them out. It reminds me of the old joke: What do you call a short-term trade that goes bad? Answer: An investment. He says the rent covers about half his monthly mortgage, tax, and condo fee.

Here's the thing: Developers can always construct a new condo building in downtown Miami. But as Jack says, "They aren't building anymore beach." Jack made a bad investment. He's stuck with two condos he never wanted and he's losing money every month. But at least his initial investment is still intact. If he'd bought downtown, he'd be sitting on a 250% loss right now... on top of the monthly bleeding. Besides, the beachfront market will recover before the downtown market, and it'll rise faster when the next boom comes along. 

"Thank God we bought on the beach," he says.

The time to buy Miami condos is not here yet. The worst of the decline may be behind us, but I expect it'll take three or four years for this market to find a bottom. We can still take a lesson from Jack: Always buy beachfront. There's less downside and more upside.

In Detroit, "beachfront" is a mansion in Grosse Pointe next to the country club, with views of Lake Saint Clair. In Argentina, beachfront is an apartment in Buenos Aires' Recoleta neighborhood. In Las Vegas, it's a penthouse on the Strip.

The stock market has its beachfront, too. When the time comes to invest in homebuilders again, I'll buy NVR. It's by far the best-managed homebuilder. When financials find a bottom, I'll buy Wells Fargo, the elite bank that counts Warren Buffett as a huge shareholder.

What's the best deal in "beachfront" right now? I like mint condition pre-1933 gold coins. They're almost as cheap as the "downtown" common bullion coins, and they're in an uptrend after a 10-year bear market...

Good investing,

Tom

P.S. Malaysia? Yes... I'll be in Asia for the next month and a half, researching investment opportunities. If you're close by or if you'd like to hear about a specific subject, write us a note at editorialfeedback@dailywealth.com.





Market Notes


THE MARKET LIKES HEALTH CARE AND BIOTECH

Our job at DailyWealth is to show you the biggest-upside, lowest-downside investments in the world. That's why we've been writing about biotech lately.

We believe you could see biotech stocks gain hundreds of percent in the next few years. More so than any other sector, biotech tends to move in giant boom and bust trends. The signs of a new "boom" are popping up daily...

Loads of individual biotech companies are hitting new highs right now. The S&P Biotech ETF is regularly hitting new highs. The world's largest biotech firm, Genentech, is the subject of a huge buyout story. And here's this week's sign: new highs for the "big boy" of health care, Johnson & Johnson.

J&J is like a huge health care hedge fund. It frequently inhales small medical and drug companies. It receives revenue from drugs, medical devices, and consumer products. Said in English, J&J makes money by selling everything from Sudafed to scalpels to schizophrenia drugs. It's a terrific gauge of sentiment toward health care and drug investments.

As you can see from J&J's uptrend, sentiment toward the sector is good... which means it's "buy time" for the drug and biotech sectors.


Recent Articles


  • Porter's Latest Prediction Just Came True
    By Justin Brill
    Saturday, February 17, 2018

    Last summer, Stansberry Research founder Porter Stansberry warned that a significant stock market correction was now certain for the first time in years. Surely, Porter is even more bearish now? Not exactly...

  • The One Secret to Thriving in 2018
    By Chris Mayer
    Friday, February 16, 2018

    We all have the same questions: What awaits us this year? What dangers lie ahead? What opportunities? What should we do next?

  • Why Inflation REALLY Matters to Investors
    By Dr. Steve Sjuggerud
    Thursday, February 15, 2018

    Was it a coincidence that inflation soared at the same time the stock market crashed? To find out, let's look a little further back in history...

  • Why the Crypto Correction Is a Good Thing
    By Tama Churchouse
    Wednesday, February 14, 2018

    In the world of crypto assets, a fire is raging right now...

  • 100% Chance of New Highs in the Next Six Months
    By Dr. Steve Sjuggerud
    Tuesday, February 13, 2018

    Over the past 90 years, 100% of the time, stocks have been higher after going through what they just went through...